Asclemed USA Inc. dba Enovachem Pharmaceuticals recalls Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Eno…
- Recall date
- March 19, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0330-2021
- FDA classification
- Class III
- Brand / firm
- Asclemed USA Inc. dba Enovachem Pharmaceuticals
- Sold / distributed
- Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.
Why it was recalled
Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608
Get recall alerts
Free email alert whenever Asclemed USA Inc. dba Enovachem Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Asclemed USA Inc. dba Enovachem Pharmaceuticals